TALPHERA, INC. (TLPH) CMO surrenders 2,118 shares for RSU taxes

Rhea-AI Filing Summary

TALPHERA, INC. Chief Medical Officer Aslam Shakil reported a tax-withholding share disposition related to vesting restricted stock units. On this Form 4, 2,118 shares of common stock were surrendered back to the company at an effective price of $0.7223 per share to cover required tax withholdings. After this transaction, Shakil directly holds 81,060 shares of TALPHERA common stock. The filing records a compensation-related tax event rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Aslam Shakil

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	2,118	$0.7223	$2K

Holdings After Transaction: Common Stock — 81,060 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares surrendered: 2,118 shares Reporting price per share: $0.7223 per share Shares held after transaction: 81,060 shares

3 metrics

Shares surrendered 2,118 shares Surrendered to issuer for RSU tax withholdings

Reporting price per share $0.7223 per share Value used for tax-withholding disposition

Shares held after transaction 81,060 shares Direct TALPHERA common stock ownership after Form 4 event

Key Terms

RSUs, tax withholdings, tax-withholding disposition, Common Stock, +1 more

5 terms

RSUs financial

"due to the vesting of RSUs."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

tax withholdings financial

"to pay required tax withholdings due to the vesting"

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Chief Medical Officer financial

"officer_title": "Chief Medical Officer""

A chief medical officer is a senior executive responsible for overseeing the health and medical strategies within an organization, often in the healthcare or pharmaceutical sectors. They play a key role in guiding decisions related to medical research, product safety, and healthcare policies, which can impact a company's reputation and success. For investors, understanding the chief medical officer's role helps gauge how well a company manages medical risks and advances its healthcare goals.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aslam Shakil

(Last) (First) (Middle)

C/O TALPHERA, INC.

1850 GATEWAY DRIVE, SUITE 175

(Street)

SAN MATEO CALIFORNIA 94404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TALPHERA, INC. [ TLPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		F		2,118(1)	D	$0.7223	81,060	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

	/s/ Martha Adler, Attorney-in-Fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TALPHERA (TLPH) report for Aslam Shakil?

TALPHERA reported that Chief Medical Officer Aslam Shakil surrendered 2,118 common shares to the company. The shares were delivered to satisfy required tax withholdings triggered by the vesting of restricted stock units, as reflected in a Form 4 insider filing.

Was Aslam Shakil’s TALPHERA (TLPH) transaction an open-market sale?

No, the Form 4 describes a tax-withholding disposition, not an open-market sale. Shakil surrendered 2,118 shares back to TALPHERA to pay tax obligations arising from vested RSUs, according to the transaction code F and accompanying footnote.

How many TALPHERA (TLPH) shares does Aslam Shakil hold after this Form 4?

Following the reported tax-withholding disposition, Aslam Shakil directly holds 81,060 shares of TALPHERA common stock. This post-transaction balance is disclosed in the Form 4 as the total shares owned after surrendering 2,118 shares for tax withholdings tied to RSU vesting.

What does transaction code F mean in the TALPHERA (TLPH) Form 4?

Transaction code F on the TALPHERA Form 4 indicates payment of tax liability or exercise price by delivering securities. Here, it reflects 2,118 shares surrendered by Aslam Shakil to cover required tax withholdings resulting from the vesting of restricted stock units.

What price per share was used in Aslam Shakil’s TALPHERA (TLPH) tax-withholding transaction?

The Form 4 shows an effective price of $0.7223 per TALPHERA common share for the 2,118 shares surrendered. This price is used solely for reporting the value of the shares delivered to the issuer to satisfy tax obligations from RSU vesting.